LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

Search

Artivion Inc

Closed

SectorHealthcare

29.53 -0.71

Overview

Share price change

24h

Current

Min

29.53

Max

29.81

Key metrics

By Trading Economics

Income

16M

-505K

Sales

1.7M

99M

EPS

-0.012

Profit margin

-0.51

Employees

1,600

EBITDA

2.7M

2.1M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+11.11% upside

Dividends

By Dow Jones

Next Earnings

7 Aug 2025

Market Stats

By TradingEconomics

Market Cap

333M

1.3B

Previous open

30.24

Previous close

29.53

News Sentiment

By Acuity

50%

50%

154 / 381 Healthcare

Artivion Inc Chart

Past performance is not a reliable indicator of future results.

Related News

19 Jun 2025, 15:04 UTC

Acquisitions, Mergers, Takeovers

UniCredit's Banco BPM Bid Gets Conditional EU Nod -- Update

19 Jun 2025, 14:33 UTC

Acquisitions, Mergers, Takeovers

UniCredit's Banco BPM Bid Gets Conditional EU Nod

19 Jun 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Uncertainty Over Israel-Iran Conflict -- Market Talk

19 Jun 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19 Jun 2025, 20:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Home Depot Bid Kicks Off a Battle for $5 Billion Building-Products Company -- WSJ

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Home Depot Privately Made Bid for Building-Products Distributor GMS, Sources Say -- WSJ

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Competing Offers Could Prompt Bidding War for GMS, Sources Say -- WSJ

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Offer From Home Depot Comes as QXO Makes Unsolicited Proposal at $95.20 Per Share -- WSJ

19 Jun 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

Worthington Buys Elgen Manufacturing for About $93M, Funded With Cash on Hand

19 Jun 2025, 17:01 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises Says Elgen Will Become Part of Its Building Products Segment

19 Jun 2025, 17:01 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises Acquires Elgen Manufacturing >WOR

19 Jun 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19 Jun 2025, 16:20 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

19 Jun 2025, 15:37 UTC

Market Talk

European Gas Soars on Middle East Escalation Fears -- Market Talk

19 Jun 2025, 15:16 UTC

Market Talk

Copper Prices Look Set to Fall Over Third Quarter, Citi Says -- Market Talk

19 Jun 2025, 15:16 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

19 Jun 2025, 15:10 UTC

Market Talk

Dollar Rises as Israel-Iran Conflict Intensifies -- Market Talk

19 Jun 2025, 15:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 Jun 2025, 15:02 UTC

Market Talk

Oil Climbs 2% as Israel-Iran Tensions Mount, With U.S. Role in Focus -- Market Talk

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU: UniCredit Committed to Divest 209 Physical Branches in Overlap Areas Across Italy

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU: UniCredit Commitments Fully Address Competition Concerns Identified

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU Rejected Request From Italian Competition Authority to Refer Deal for National Review

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU Approves UniCredit's Acquisition of Banco BPM, Subject to Conditions

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU Says There Are No Compelling Reasons to Justify Referral to Italy

19 Jun 2025, 13:58 UTC

Market Talk

Market Talk Roundup: BOE Holds Rates as Focus Turns to Likely August Cut

19 Jun 2025, 13:58 UTC

Market Talk

Market Talk Roundup: BOE Holds Rates as Focus -2-

19 Jun 2025, 13:38 UTC

Market Talk

Canadian Small Firms Appear to Be Coping With Tariffs -- Market Talk

19 Jun 2025, 13:33 UTC

Market Talk

BOE Likely to Cut Rates If Firms' Pricing Power Weakens -- Market Talk

19 Jun 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Peer Comparison

Price change

Artivion Inc Forecast

Price Target

By TipRanks

11.11% upside

12 Months Forecast

Average 33 USD  11.11%

High 35 USD

Low 30 USD

Based on 5 Wall Street analysts offering 12 month price targets forArtivion Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Sentiment

By Acuity

154 / 381 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Artivion Inc

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.